Moxostad (Moxonidine)

Moxonidine is used to manage hypertension, a condition characterized by elevated arterial pressure.

• Essential hypertension: lowers systolic and diastolic blood pressure and reduces cardiovascular risk.
• Secondary hypertension: helps control blood pressure when caused by underlying disorders.
• Hypertension with metabolic syndrome: improves blood pressure control while having a neutral effect on metabolic parameters.

• Moxonidine selectively stimulates central imidazoline I1 receptors in the medulla oblongata, which diminishes sympathetic outflow. The reduced sympathetic activity leads to decreased peripheral vascular resistance and lower arterial blood pressure, providing antihypertensive effects without significant direct cardiac depression.

Moxonidine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Dry mouth: sensation of oral dryness.
• Fatigue: feeling of tiredness or reduced energy.
• Dizziness: light‑headedness, especially when standing.
• Headache: mild to moderate head pain.
• Nausea: upset stomach or urge to vomit.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe hypotension: markedly low blood pressure requiring medical attention.
• Bradycardia: abnormally slow heart rate.
• Hepatic dysfunction: signs of liver injury such as jaundice.
• Allergic reactions: rash, itching, or swelling.
• Arrhythmia: irregular heart rhythm.
• Syncope: fainting episodes.

Before initiating therapy with Moxostad, several safety considerations should be observed.

• Blood pressure monitoring: check regularly to avoid excessive hypotension.
• Renal impairment: dose may need adjustment in patients with reduced kidney function.
• Elderly patients: start with the lowest effective dose and monitor closely.
• Abrupt discontinuation: taper gradually to prevent rebound hypertension.
• Hepatic disease: avoid use in severe liver dysfunction.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Moxostad can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

• Combined antihypertensives: may cause additive blood‑pressure lowering effects leading to hypotension.
• Clonidine: additive central sympatholytic action can result in severe hypotension.
• MAO inhibitors: potential for unpredictable cardiovascular responses.

Moderate Interactions (Monitor Closely)

• NSAIDs: may blunt the antihypertensive effect of moxonidine.
• Diuretics: increase risk of electrolyte disturbances and excessive blood‑pressure reduction.
• Lithium: moxonidine may raise lithium serum concentrations, requiring level monitoring.